Literature DB >> 8826573

Phenazopyridine in urinary tract infections.

S A Zelenitsky1, G G Zhanel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8826573     DOI： 10.1177/106002809603000727

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  6 in total

Review 1.  Neurorehabilitation in multiple sclerosis--what is the evidence-base?

Authors:  Jürg Kesselring
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  The etiology and management of recurrent urinary tract infections in postmenopausal women.

Authors:  Carrie Jung; Linda Brubaker
Journal:  Climacteric       Date:  2019-01-09       Impact factor: 3.005

3.  Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice.

Authors:  Chong Wang; Yuan Zhang; Dongdong Zhao; Yuanhui Huo; Jieru Xie; Xian Zhang; Hong Luo; Huaxi Xu; Yun-Wu Zhang
Journal:  Neuropsychopharmacology       Date:  2022-07-11       Impact factor: 8.294

4.  Systematic discovery of multicomponent therapeutics.

Authors:  Alexis A Borisy; Peter J Elliott; Nicole W Hurst; Margaret S Lee; Joseph Lehar; E Roydon Price; George Serbedzija; Grant R Zimmermann; Michael A Foley; Brent R Stockwell; Curtis T Keith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

5.  Chemical composition and antifungal effect of hydroalcoholic extract of Allium tripedale (Tvautv.) against Candida species.

Authors:  M Shirani; A Samimi; H Kalantari; M Madani; A Kord Zanganeh
Journal:  Curr Med Mycol       Date:  2017-03

6.  Delayed-type drug eruption to phenazopyridine (pyridium) confirmed with patch testing.

Authors:  Winnie W Y Yeung; Christina S M Wong; Wai-Yan Leung; Philip H Li
Journal:  Asia Pac Allergy       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.